Lixte Biotechnology Holdings Stock Price History
| LIXT Stock | USD 3.28 0.06 1.86% |
Below is the normalized historical share price chart for Lixte Biotechnology Holdings extending back to September 21, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lixte Biotechnology stands at 3.28, as last reported on the 24th of April, with the highest price reaching 3.57 and the lowest price hitting 3.21 during the day.
If you're considering investing in Lixte Stock, it is important to understand the factors that can impact its price. Lixte Biotechnology is dangerous given 3 months investment horizon. Lixte Biotechnology has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.04% are justified by taking the suggested risk. Use Lixte Biotechnology Risk Adjusted Performance of 0.0752, downside deviation of 6.15, and Mean Deviation of 5.14 to evaluate company specific risk that cannot be diversified away.
At this time, Lixte Biotechnology's Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 51.4 M in 2024, whereas Common Stock is likely to drop 213.75 in 2024. . At this time, Lixte Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.01 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.10) in 2024. Lixte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of September 2007 | 200 Day MA 2.6857 | 50 Day MA 2.8038 | Beta (0.29) |
Lixte |
Sharpe Ratio = 0.1152
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LIXT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.06 actual daily | 80 80% of assets are less volatile |
Expected Return
| 1.04 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Lixte Biotechnology is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lixte Biotechnology by adding it to a well-diversified portfolio.
Price Book 15.548 | Book Value 0.22 | Enterprise Value 6.5 M | Enterprise Value Ebitda (1.38) | Shares Float 2 M |
Lixte Biotechnology Stock Price History Chart
There are several ways to analyze Lixte Stock price data. The simplest method is using a basic Lixte candlestick price chart, which shows Lixte Biotechnology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 2, 2024 | 3.7 |
| Lowest Price | February 5, 2024 | 2.02 |
Lixte Biotechnology April 24, 2024 Stock Price Synopsis
Various analyses of Lixte Biotechnology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lixte Stock. It can be used to describe the percentage change in the price of Lixte Biotechnology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lixte Stock.| Lixte Biotechnology Price Action Indicator | (0.08) | |
| Lixte Biotechnology Price Daily Balance Of Power | 0.17 | |
| Lixte Biotechnology Accumulation Distribution | 1,622 | |
| Lixte Biotechnology Price Rate Of Daily Change | 1.02 |
Lixte Biotechnology April 24, 2024 Stock Price Analysis
Lixte Stock Price History Data
The price series of Lixte Biotechnology for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 1.84 with a coefficient of variation of 19.87. The daily prices for the period are spread out with arithmetic mean of 2.63. The median price for the last 90 days is 2.45. The company underwent 1:10 stock split on 5th of June 2023. Lixte Biotechnology issued dividends to stockholders on 2020-11-20.| Open | High | Low | Close | Volume | ||
| 04/24/2024 | 3.36 | 3.57 | 3.21 | 3.28 | 16,082 | |
| 04/23/2024 | 3.30 | 3.54 | 3.11 | 3.22 | 40,467 | |
| 04/22/2024 | 3.54 | 3.59 | 3.35 | 3.35 | 21,756 | |
| 04/19/2024 | 3.46 | 3.54 | 3.33 | 3.47 | 11,174 | |
| 04/18/2024 | 3.48 | 3.48 | 3.35 | 3.35 | 18,311 | |
| 04/17/2024 | 3.47 | 3.50 | 3.25 | 3.33 | 12,501 | |
| 04/16/2024 | 3.35 | 3.53 | 3.35 | 3.50 | 22,066 | |
| 04/15/2024 | 3.42 | 3.48 | 3.28 | 3.30 | 18,906 | |
| 04/12/2024 | 3.41 | 3.50 | 3.30 | 3.48 | 17,421 | |
| 04/11/2024 | 3.46 | 3.51 | 3.33 | 3.38 | 17,655 | |
| 04/10/2024 | 3.31 | 3.50 | 3.29 | 3.36 | 60,049 | |
| 04/09/2024 | 3.34 | 3.65 | 3.17 | 3.31 | 136,946 | |
| 04/08/2024 | 3.35 | 3.74 | 3.12 | 3.31 | 236,044 | |
| 04/05/2024 | 3.21 | 3.46 | 3.18 | 3.20 | 54,802 | |
| 04/04/2024 | 3.15 | 3.57 | 3.15 | 3.42 | 56,879 | |
| 04/03/2024 | 3.40 | 3.80 | 3.10 | 3.10 | 126,249 | |
| 04/02/2024 | 3.50 | 3.87 | 3.00 | 3.70 | 292,009 | |
| 04/01/2024 | 3.27 | 3.60 | 2.90 | 3.57 | 332,258 | |
| 03/28/2024 | 3.51 | 3.79 | 3.15 | 3.38 | 879,579 | |
| 03/27/2024 | 3.99 | 4.40 | 3.05 | 3.52 | 30,986,295 | |
| 03/26/2024 | 2.26 | 2.26 | 2.26 | 2.26 | 416.00 | |
| 03/25/2024 | 2.26 | 2.26 | 2.26 | 2.26 | 651.00 | |
| 03/22/2024 | 2.29 | 2.29 | 2.20 | 2.20 | 1,580 | |
| 03/21/2024 | 2.26 | 2.31 | 2.16 | 2.31 | 6,110 | |
| 03/20/2024 | 2.26 | 2.31 | 2.24 | 2.31 | 2,094 | |
| 03/19/2024 | 2.39 | 2.39 | 2.30 | 2.30 | 1,474 | |
| 03/18/2024 | 2.42 | 2.45 | 2.30 | 2.45 | 2,925 | |
| 03/15/2024 | 2.33 | 2.57 | 2.30 | 2.31 | 3,392 | |
| 03/14/2024 | 2.43 | 2.43 | 2.25 | 2.27 | 5,355 | |
| 03/13/2024 | 2.47 | 2.53 | 2.38 | 2.38 | 2,691 | |
| 03/12/2024 | 2.37 | 2.61 | 2.24 | 2.36 | 52,772 | |
| 03/11/2024 | 2.41 | 2.51 | 2.25 | 2.51 | 17,057 | |
| 03/08/2024 | 2.54 | 2.60 | 2.43 | 2.43 | 6,810 | |
| 03/07/2024 | 2.45 | 2.55 | 2.40 | 2.54 | 14,068 | |
| 03/06/2024 | 2.46 | 2.49 | 2.40 | 2.42 | 1,129 | |
| 03/05/2024 | 2.50 | 2.53 | 2.39 | 2.46 | 6,262 | |
| 03/04/2024 | 2.50 | 2.55 | 2.46 | 2.47 | 2,761 | |
| 03/01/2024 | 2.72 | 2.72 | 2.42 | 2.42 | 17,217 | |
| 02/29/2024 | 2.72 | 2.72 | 2.51 | 2.60 | 18,642 | |
| 02/28/2024 | 2.55 | 2.74 | 2.35 | 2.70 | 54,850 | |
| 02/27/2024 | 2.28 | 2.82 | 2.20 | 2.67 | 116,028 | |
| 02/26/2024 | 2.13 | 2.45 | 1.90 | 2.21 | 1,571,682 | |
| 02/23/2024 | 2.37 | 2.38 | 2.22 | 2.22 | 4,888 | |
| 02/22/2024 | 2.35 | 2.37 | 2.35 | 2.37 | 5,141 | |
| 02/21/2024 | 2.69 | 2.75 | 2.32 | 2.32 | 14,652 | |
| 02/20/2024 | 2.76 | 2.77 | 2.63 | 2.68 | 5,325 | |
| 02/16/2024 | 2.82 | 2.82 | 2.32 | 2.79 | 23,726 | |
| 02/15/2024 | 2.79 | 2.79 | 2.72 | 2.72 | 6,525 | |
| 02/14/2024 | 2.82 | 2.84 | 2.66 | 2.67 | 10,285 | |
| 02/13/2024 | 2.55 | 2.73 | 2.35 | 2.73 | 6,074 | |
| 02/12/2024 | 2.41 | 2.78 | 2.41 | 2.60 | 26,376 | |
| 02/09/2024 | 2.11 | 2.40 | 2.11 | 2.31 | 25,385 | |
| 02/08/2024 | 2.18 | 2.18 | 2.00 | 2.06 | 13,237 | |
| 02/07/2024 | 2.16 | 2.17 | 2.06 | 2.11 | 3,058 | |
| 02/06/2024 | 2.08 | 2.17 | 2.08 | 2.09 | 1,505 | |
| 02/05/2024 | 2.12 | 2.22 | 2.02 | 2.02 | 6,906 | |
| 02/02/2024 | 2.11 | 2.12 | 2.05 | 2.05 | 4,451 | |
| 02/01/2024 | 2.11 | 2.15 | 1.95 | 2.12 | 12,702 | |
| 01/31/2024 | 2.09 | 2.10 | 2.00 | 2.10 | 5,144 | |
| 01/30/2024 | 2.16 | 2.20 | 2.09 | 2.12 | 3,619 | |
| 01/29/2024 | 2.33 | 2.43 | 2.07 | 2.15 | 38,427 |
About Lixte Biotechnology Stock history
Lixte Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lixte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lixte Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lixte Biotechnology stock prices may prove useful in developing a viable investing in Lixte Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.9 M | 1.8 M | |
| Net Loss | -6.1 M | -5.8 M |
Lixte Biotechnology Quarterly Net Working Capital |
|
Lixte Biotechnology Stock Technical Analysis
Lixte Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Lixte Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lixte Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Lixte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lixte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0752 | |||
| Jensen Alpha | 0.8297 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.1411 | |||
| Treynor Ratio | 0.6619 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Lixte Stock analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Lixte Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lixte Biotechnology. If investors know Lixte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lixte Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Return On Assets (0.64) | Return On Equity (1.11) |
The market value of Lixte Biotechnology is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotechnology's market value can be influenced by many factors that don't directly affect Lixte Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lixte Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.